PGGM’s Voting Revisited for 2024
It is time to push for more global progress on diversity and PGGM will exercise its voting rights accordingly, says Rogier Snijdewind of PGGM in his latest blog.
Rogier Snijdewind
Senior Advisor Responsible Investment
My publications
Voting Matters - taking responsibility as a critical shareholder
As the 2023 AGM season starts, our voting and shareholder engagement are reinforcing each other, says Rogier Snijdewind.
The next chapter in Access to Medicine
PGGM aims to enhance both access and affordability of medicines through various ways, such as investing in companies that are contributing to having a positive impact on SDG 3 (Good Health and Wellbeing) and by running a dedicated Access to Healthcare engagement program with investee companies.
Access to health care in exceptional times
Investors finance the different links that together form the global production chains for medical devices, pharmaceutical and other care-related products. Governments and companies must ensure that these products are available all over the world.
Healthy, but not at all costs
Manufacturers of pharmaceuticals take inappropriate risks if they charge excessive prices for their medications. As a shareholder, we do not want to see maximisation of profit at the expense of health care.